Expanding pancreas donor pool by evaluation of unallocated organs after brain death: Study protocol clinical trial (SPIRIT Compliant)

Yakup Kulu, Elias Khajeh, Omid Ghamarnejad, Mohammadsadegh Nikdad, Mohammadsadegh Sabagh, Sadeq Ali-Hasan-Al-Saegh, Silvio Nadalin, Markus Quante, Przemyslaw Pisarski, Bernd Jänigen, Christoph Reißfelder, Markus Mieth, Christian Morath, Benjamin Goeppert, Peter Schirmacher, Oliver Strobel, Thilo Hackert, Martin Zeier, Rainer Springel, Christina Schleicher, Markus W Büchler, Arianeb Mehrabi, Yakup Kulu, Elias Khajeh, Omid Ghamarnejad, Mohammadsadegh Nikdad, Mohammadsadegh Sabagh, Sadeq Ali-Hasan-Al-Saegh, Silvio Nadalin, Markus Quante, Przemyslaw Pisarski, Bernd Jänigen, Christoph Reißfelder, Markus Mieth, Christian Morath, Benjamin Goeppert, Peter Schirmacher, Oliver Strobel, Thilo Hackert, Martin Zeier, Rainer Springel, Christina Schleicher, Markus W Büchler, Arianeb Mehrabi

Abstract

Background: Pancreas graft quality directly affects morbidity and mortality rates after pancreas transplantation (PTx). The criteria for pancreas graft allocation are restricted, which has decreased the number of available organs. Suitable pancreatic allografts are selected based on donor demographics, medical history, and the transplant surgeon's assessment of organ quality during procurement. Quality is assessed based on macroscopic appearance, which is biased by individual experience and personal skills. Therefore, we aim to assess the histopathological quality of unallocated pancreas organs to determine how many unallocated organs are potentially of suitable quality for PTx.

Methods and analysis: This is a multicenter cross-sectional explorative study. The demographic data and medical history of donor and cause of rejection of the allocation of graft will be recorded. Organs of included donors will be explanted and macroscopic features such as weight, color, size, and stiffness will be recorded by 2 independent transplant surgeons. A tissue sample of the organ will be fixed for further microscopic assessments. Histopathologic assessments will be performed as soon as a biopsy can be obtained. We will evaluate up to 100 pancreata in this study.

Result: This study will evaluate the histopathological quality of unallocated pancreas organs from brain-dead donors to determine how many of these unallocated organs were potentially suitable for transplantation based on a histopathologic evaluation of organ quality.

Conclusion: The comprehensive findings of this study could help to increase the pancreas graft pool, overcome organ shortage, reduce the waiting time, and also increase the number of PTx in the future. Registration number: ClinicalTrials.gov: NCT04127266.

Conflict of interest statement

The authors declare that they have no Conflicts of interests.

Figures

Figure 1
Figure 1
Study design flow chart. ET = Eurotransplant, DTG = German Transplantation Society.

References

    1. Kandaswamy R, Stock PG, Gustafson SK, et al. OPTN/SRTR 2015 annual data report: pancreas. Am J Transplant 2017;17: Suppl 1: 117–73.
    1. McCullough KP, Keith DS, Meyer KH, et al. Kidney and pancreas transplantation in the United States, 1998–2007: access for patients with diabetes and end-stage renal disease. Am J Transplant 2009;9:894–906.
    1. Morath C, Schmied B, Mehrabi A, et al. Simultaneous pancreas-kidney transplantation in type 1 diabetes. Clin Transplant 2009;23:115–20.
    1. Heidt DG, Burant C, Simeone DM. Total pancreatectomy: indications, operative technique, and postoperative sequelae. J Gastrointest Surg 2007;11:209–16.
    1. Kulu Y, Schmied BM, Werner J, et al. Total pancreatectomy for pancreatic cancer: indications and operative technique. HPB (Oxford) 2009;11:469–75.
    1. Mehrabi A, Golriz M, Adili-Aghdam F, et al. Expanding the indications of pancreas transplantation alone. Pancreas 2014;43:1190–3.
    1. Ryan EA, Bigam D, Shapiro A. Current indications for pancreas or islet transplant. Diabetes Obes Metab 2006;8:1–7.
    1. van Dellen D, Worthington J, Mitu-Pretorian OM, et al. Mortality in diabetes: pancreas transplantation is associated with significant survival benefit. Nephrol Dial Transplant 2013;28:1315–22.
    1. Robertson RP, Nathan DM, Muylder JE. Pancreas and islet transplantation in diabetes mellitus. UpToDate, Hirsch, IB. Ed. UpToDate, Waltham, MA. (Accessed on January 24 2019). 2016 Mar 7.
    1. Esmaeilzadeh M, Fonouni H, Golriz M, et al. Evaluation of the modified HTK solution in pancreas transplantation-An experimental model. Asian J Surg 2016;39:66–73.
    1. Fonouni H, Tahmasbi Rad M, Esmaeilzadeh M, et al. A simplified technique of pancreas transplantation in a porcine model. Eur Surg Res 2015;54:24–33.
    1. Malaise J, De Roover A, Squifflet JP, et al. Immunosuppression in pancreas transplantation the euro SPK trials and beyond. Acta Chir Belg 2008;108:673–8.
    1. Schmied BM, Muller SA, Mehrabi A, et al. Immunosuppressive standards in simultaneous kidney-pancreas transplantation. Clin Transplant 2006;20: Suppl 17: 44–50.
    1. Franz C, Görtz M, Wührl M, et al. The role of pre-procurement pancreas suitability score (P-PASS) and Pancreas Donor Risk Index (PDRI) in the outcome of simultaneous pancreas and kidney or pancreas after kidney transplantation. Ann Transplant 2019;24:439–45.
    1. Thompson ER, Irwin EA, Trotter P, et al. UK registry analysis of donor substance misuse and outcomes following pancreas transplantation. Clin Transplant 2019;33:e13481.
    1. Barlow AD, Hamed MO, Mallon DH, et al. Use of ex vivo normothermic perfusion for quality assessment of discarded human donor pancreases. Am J Transplant 2015;15:2475–82.
    1. Proneth A, Schnitzbauer AA, Zeman F, et al. Extended pancreas donor program - the EXPAND study rationale and study protocol. Transplant Res 2013;2:12.
    1. Wolfe R, Roys E, Merion R. Trends in organ donation and transplantation in the United States, 1999-2008. Am J Transplant 2010;10:961–72.
    1. Wiseman AC. Simultaneous pancreas kidney transplantation: a critical appraisal of the risks and benefits compared with other treatment alternatives. Adv Chronic Kidney Dis 2009;16:278–87.
    1. Stratta RJ, Gruessner AC, Odorico JS, et al. Pancreas transplantation: an alarming crisis in confidence. Am J Transplant 2016;16:2556–62.
    1. Rahmel A, Meiser B. Eurotransplant International Foundation Annual Report 2013. Leiden, The Netherlands: CIP-Gegevens Koninklijke Bibliotheek; 2013.
    1. Wunderlich H, Brockmann JG, Voigt R, et al. DTG procurement guidelines in heart beating donors. Transpl Int 2011;24:733–57.
    1. Vinkers MT, Rahmel AO, Slot MC, et al. How to recognize a suitable pancreas donor: a Eurotransplant study of preprocurement factors. Transplant Proc 2008;40:1275–8.
    1. Loss J, Drewitz KP, Schlitt HJ, et al. Accept or refuse? Factors influencing the decision-making of transplant surgeons who are offered a pancreas: results of a qualitative study. BMC Surg 2013;13:47.
    1. Loss M, Drewitz KP, Apfelbacher CJ, et al. Why offered pancreases are refused in the allocation process-a descriptive study using routine data from eurotransplant. Transplantation 2013;95:1134–41.
    1. Andreoni KA, Brayman KL, Guidinger MK, et al. Kidney and pancreas transplantation in the United States, 1996-2005. Am J Transplant 2007;7:1359–75.
    1. Salvalaggio P, Schnitzler M, Abbott K, et al. Patient and graft survival implications of simultaneous pancreas kidney transplantation from old donors. Am J Transplant 2007;7:1561–71.
    1. Drewitz KP, Loss M, Loss J, et al. Predictors of non-transplantation of adult donor organs--an observational study using routine data from Eurotransplant. BMC Health Serv Res 2014;14:584.
    1. Boggi U, Del Chiaro M, Signori S, et al. Pancreas transplants from donors aged 45 years or older. Transplant Proc 2005;37:1265–7.
    1. Fridell JA, Mangus RS, Taber TE, et al. Growth of a nation part I: impact of organ donor obesity on whole-organ pancreas transplantation. Clin Transplant 2011;25:E225–32.
    1. Giorgakis E, Mathur AK, Chakkera HA, et al. Solid pancreas transplant: pushing forward. World J Transplant 2018;8:237–51.
    1. Proneth A, Schnitzbauer AA, Schenker P, et al. Extended pancreas donor program - the EXPAND study a prospective multicenter trial testing the use of pancreas donors older than 50 years. Transplantation 2018;102:1330–7.
    1. Ruggenenti P, Silvestre C, Boschiero L, et al. Long-term outcome of renal transplantation from octogenarian donors: a multicenter controlled study. Am J Transplant 2017;17:3159–71.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel